Japan
Japan's melanoma market urged to ramp up social media activity
Companies were advised to include content providing emotional support for patients.
Japan's melanoma market urged to ramp up social media activity
Companies were advised to include content providing emotional support for patients.
Digital support for type 2 diabetes patients remain limited
This presents opportunities for digital marketing of T2D therapeutics.
Japan signs deals for vaccine preorders four times the population
The move was lauded as local vaccines remain in Phase II stage.
Fujitsu, Tokyo Shinagawa to develop AI-supported diagnosis of COVID-19 pneumonia
The system is expected to deliver early detection of cases, even when the probablity of infection is low.
COVID-19 dampens Japan's pharma market
Reduced healthcare spending will affect multinationals' capabilities to launch new products.
KMU Hospital orders health tracker ‘Mother'
However, the delivery date is still unknown amid destabilised production.
Challenges plague Asia's health tech assessment programmes
Solutions focus on improving HTAs’ integration to current drug pricing schemes.
MORE Health launches international access to Japan's health services
The partnership with Japan’s Integrity Health will deliver a remote health diagnosis.
Tokyo tops hospital city rankings
It got stellar scores for access and quality of care.
Japanese pharma sales take hit from 'opaque' pricing system
It will grow at a CAGR of 2.3% to $124b in 2023.
Rentschler strengthens Japanese ties with Summit Pharmaceuticals
The East Asian country is the world’s third largest pharmaceuticals market.
Rentschler strengthens Japanese ties with Summit Pharmaceuticals
The East Asian country is the world’s third largest pharmaceuticals market.
Rentschler strengthens Japanese ties with Summit Pharmaceuticals
The East Asian country is the world’s third largest pharmaceuticals market.
Sumitomo Dainippon Pharma to acquire 10% stake in Roivant for $3b
The pharma will assume ownership interests in five biopharma companies.
Pricing reforms threaten pharma investment in Japan
Fewer companies may enjoy full benefit of the premium under the new requirements.
Japan to build 10 AI-based hospitals by 2022
It plans to invest more than $100m to tackle the lack of medical personnel and rise in medical expenses.
Japan's pharmaceutical growth hampered by pricing pressures: Fitch Solutions
Sales are expected to fall 30% to US$62b by 2025 once the new annual price review takes effect.
Resource Center
Read Here
Advertise
Sign Up
Event News
Only one of two leading firms achieves 80% of their digital transformation project targets.
